Tranquilassure Cyracos Lemon Balm Extract 600 mg

by Swanson Ultra · capsule · 30 capsules

  • Off the market since December 2023 (NIH)
  • UPC 0 87614 02417 2
  • DSLD label 184919
  • Serving 1 capsule

Tranquilassure Cyracos Lemon Balm Extract 600 mg by Swanson Ultra lists one ingredient: 600 mg of cyracos lemon balm extract per serving of 1 capsule. Its current label entered the NIH Dietary Supplement Label Database on April 25, 2019.

What is in Tranquilassure Cyracos Lemon Balm Extract 600 mg?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Tranquilassure Cyracos Lemon Balm Extract 600 mg: Supplement Facts rows against the market (DSLD label 184919, January 2026 release)
IngredientAmount% DVAmong products listing it
Cyracos Lemon Balm extractas Hydroxycinnamic Acids, Rosmarinic AcidCyracos Lemon Balm extract (Form: standardized to 14% Hydroxycinnamic Acids, and 7% Rosmarinic Acid) PlantPart: leaf Genus: Melissa Species: officinalis600 mgLemon balm in Tranquilassure Cyracos Lemon Balm Extract 600 mg against 475 products600 mg per serving; the middle half of products list 50 mg to 200 mg, the median 100 mg.600 mg

Higher than 90% of 475 products listing lemon balm (median 100 mg).

Source: NIH ODS Dietary Supplement Label Database, label 184919 (entered April 25, 2019), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested use: As a dietary supplement, take one capsule in the morning with water.
Warnings
Do not use if seal is broken.
Keep out of reach of children.
Warning: Do not take this product if you are pregnant or nursing.
Storage
Store in a cool, dry place.

Source: label statements in DSLD label 184919.

What else is on the label?

Other ingredients: Gelatin, Rice Flour, May contain one or both of the following.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Guaranteed purity & potency.

How many labels does Tranquilassure Cyracos Lemon Balm Extract 600 mg have?

One label is on file, entered on April 25, 2019.

  1. Label 184919 (current) Entered April 25, 2019 · off the market December 5, 2023 · 30 capsules · UPC 0 87614 02417 2

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Swanson Health Products (distributor), Fargo, ND. All Swanson Ultra products.

Where next?